Peringkat dalam Saham
#19830
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Kapitalisasi Pasar
$149.33M
Perubahan (1 hari)
-1.39%
Perubahan (1 tahun)
24.38%
Perdagangan Alpha Cognition Inc (ACOG)
Harga ACOG dengan kapitalisasi pasar B
Kapitalisasi pasar dari Alpha Cognition Inc(ACOG)
Kapitalisasi Pasar: $149.33M
Per August 2026, Alpha Cognition Inc memiliki kapitalisasi pasar sebesar $149.33M. Ini menjadikan Alpha Cognition Inc sebagai perusahaan 19830th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Alpha Cognition Inc dari 2024 hingga 2026
ACOG dibandingkan dengan 5 teratas stocks paling populer
| Harga ACOG |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.152T
|
+3,450,396.58%
|
|
|
|
|
$4.537T
|
+3,038,233.58%
|
|
|
|
|
$4.169T
|
+2,791,489.37%
|
|
|
|
|
$3.642T
|
+2,439,094.36%
|
|
|
|
|
$2.805T
|
+1,878,142.65%
|
